Form 144: 5,000 MIRM Shares Reported Sold

Morgan Stanley Smith Barney LLC submitted a Form 144 notice related to 5,000 shares of Common Stock associated with restricted stock dated 09/11/2024.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 notice related to 5,000 shares of Common Stock associated with restricted stock dated 09/11/2024. The filing shows a reported sale of 5,000 shares by Eric Bjerkholt on 06/08/2026 with a value listed as $469,073.00.

Insights

Securities Compliance Counsel

Routine Rule 144 resale notice for 5,000 restricted shares reported by an affiliated broker-dealer.

Form 144 is a statutory notice for proposed sales under Rule 144; this filing lists 5,000 shares of restricted Common Stock dated 09/11/2024. The seller is named as Eric Bjerkholt and the sale date is recorded as 06/08/2026.

Timing, volume, and dollar amount are factual here; the filing does not state whether proceeds flow to the issuer or selling holder beyond the listed value. Subsequent filings or broker confirmations would show execution details and cash‑flow treatment.

Key Figures

Form type: Form 144 Shares to be sold: 5,000 shares Reported sale date: 06/08/2026 +3 more

6 metrics

Form type Form 144 Rule 144 resale notice

Shares to be sold 5,000 shares Restricted stock dated 09/11/2024

Reported sale date 06/08/2026 Sale by Eric Bjerkholt

Reported value $469,073.00 Value shown next to the 06/08/2026 5,000-share sale

Restricted stock date 09/11/2024 Grant/issuance date for the restricted shares

Broker-dealer listed Morgan Stanley Smith Barney LLC Filer Information, Executive Financial Services

Key Terms

Restricted Stock, Form 144, Rule 144 resale notice

3 terms

Restricted Stock financial

"Securities To Be Sold | Common | 09/11/2024 | Restricted Stock"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Rule 144 resale notice regulatory

"144: Securities To Be Sold"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 04:09 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001197350
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MIRUM PHARMACEUTICALS, INC.
SEC File Number	001-38981
Address of Issuer	989 East Hillsdale Boulevard, Suite 300 Foster City CALIFORNIA 94404
Phone	(650) 667-4085
Name of Person for Whose Account the Securities are To Be Sold	ERIC BJERKHOLT
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5000	611270.00	60981227	07/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/11/2024	Restricted Stock	ISSUER			5000	09/11/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ERIC BJERKHOLT 989 East Hillsdale Boulevard, Suite 300 Foster City CA 94404	Common	06/08/2026	5000	469073.00

144: Remarks and Signature

Remarks
Date of Notice	07/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Eric L Bjerkholt
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)